Clinical Trial Update: Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated whether Botulinum toxin type A affects swallowing in patients with cervical dystonia (torticollis); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia
• Torticollis

Drugs mentioned

• Botulinum Toxin Type A (Botox) (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Torticollis | Phase 4 | Status: COMPLETED